Development and Pilot Testing of an Algorithm-Based Approach to Anticholinergic Deprescribing in Older Patients.

IF 3.4 3区 医学 Q2 GERIATRICS & GERONTOLOGY Drugs & Aging Pub Date : 2024-02-01 Epub Date: 2024-02-06 DOI:10.1007/s40266-023-01089-3
Tanja Wehran, Annette Eidam, David Czock, Jürgen Kopitz, Konstanze Plaschke, Margarete Mattern, Walter Emil Haefeli, Jürgen Martin Bauer, Hanna Marita Seidling
{"title":"Development and Pilot Testing of an Algorithm-Based Approach to Anticholinergic Deprescribing in Older Patients.","authors":"Tanja Wehran, Annette Eidam, David Czock, Jürgen Kopitz, Konstanze Plaschke, Margarete Mattern, Walter Emil Haefeli, Jürgen Martin Bauer, Hanna Marita Seidling","doi":"10.1007/s40266-023-01089-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Adverse anticholinergic drug reactions are common, yet evidence on how to reduce exposure to anticholinergic activity and reliably measure successful deprescribing is still scant. This study proposes an algorithm-based approach to evaluate and reduce anticholinergic load, and reports the results of its pilot testing.</p><p><strong>Methods: </strong>Based on published evidence and expert opinion, a list of 85 anticholinergic drugs and 21 algorithms for reducing anticholinergic load, e.g., by recommending alternative drugs with lower risk, were developed. An accompanying test battery was assembled by focusing on instruments that sensitively reflect anticholinergic load and may be sensitive to depict changes (Neuropsychological Assessment Battery to measure memory and attention, validated assessments for constipation, urinary symptoms, and xerostomia, as well as blood biomarkers). The approach was pilot-tested in a geriatric rehabilitation unit, with clinician feedback as the primary outcome and characterization of anticholinergic symptoms as the secondary outcome. The intervention was delivered by a pharmacist and a clinical pharmacologist who used the algorithms to generate personalized recommendation letters.</p><p><strong>Results: </strong>We included a total of 20 patients, 13 with anticholinergic drugs and 7 without. Recommendations were made for 22 drugs in nine patients from the intervention group, of which seven letters (78%) were considered helpful and 8/22 (36%) anticholinergic drugs were discontinued, reducing anticholinergic load in seven patients. In contrast to patients without drug change, memory assessment in patients with reduced anticholinergic load improved significantly after 2 weeks (6 ± 3 vs. -1 ± 6 points).</p><p><strong>Conclusions: </strong>The approach was well received by the participating physicians and might support standardized anticholinergic deprescribing.</p>","PeriodicalId":11489,"journal":{"name":"Drugs & Aging","volume":" ","pages":"153-164"},"PeriodicalIF":3.4000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10869417/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs & Aging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40266-023-01089-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Adverse anticholinergic drug reactions are common, yet evidence on how to reduce exposure to anticholinergic activity and reliably measure successful deprescribing is still scant. This study proposes an algorithm-based approach to evaluate and reduce anticholinergic load, and reports the results of its pilot testing.

Methods: Based on published evidence and expert opinion, a list of 85 anticholinergic drugs and 21 algorithms for reducing anticholinergic load, e.g., by recommending alternative drugs with lower risk, were developed. An accompanying test battery was assembled by focusing on instruments that sensitively reflect anticholinergic load and may be sensitive to depict changes (Neuropsychological Assessment Battery to measure memory and attention, validated assessments for constipation, urinary symptoms, and xerostomia, as well as blood biomarkers). The approach was pilot-tested in a geriatric rehabilitation unit, with clinician feedback as the primary outcome and characterization of anticholinergic symptoms as the secondary outcome. The intervention was delivered by a pharmacist and a clinical pharmacologist who used the algorithms to generate personalized recommendation letters.

Results: We included a total of 20 patients, 13 with anticholinergic drugs and 7 without. Recommendations were made for 22 drugs in nine patients from the intervention group, of which seven letters (78%) were considered helpful and 8/22 (36%) anticholinergic drugs were discontinued, reducing anticholinergic load in seven patients. In contrast to patients without drug change, memory assessment in patients with reduced anticholinergic load improved significantly after 2 weeks (6 ± 3 vs. -1 ± 6 points).

Conclusions: The approach was well received by the participating physicians and might support standardized anticholinergic deprescribing.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
开发并试点测试基于算法的老年患者抗胆碱能药物减量方法。
背景:抗胆碱能药物不良反应很常见,但如何减少抗胆碱能药物的暴露量并可靠地衡量成功减药的证据仍然很少。本研究提出了一种基于算法的方法来评估和减少抗胆碱能药物负荷,并报告了试点测试的结果:方法:根据已发表的证据和专家意见,制定了一份包含 85 种抗胆碱能药物的清单和 21 种减少抗胆碱能药物负荷的算法,例如推荐风险较低的替代药物。通过重点关注能够敏感反映抗胆碱能负荷并可能敏感描述变化的工具(用于测量记忆力和注意力的神经心理评估电池,针对便秘、泌尿系统症状和口腔干燥症的有效评估,以及血液生物标志物),建立了配套的测试电池。该方法在一家老年康复中心进行了试点测试,以临床医生的反馈作为主要结果,以抗胆碱能症状的特征作为次要结果。干预措施由一名药剂师和一名临床药理学家实施,他们使用算法生成个性化推荐信:我们共纳入了 20 名患者,其中 13 人服用了抗胆碱能药物,7 人未服用。为干预组的 9 名患者推荐了 22 种药物,其中 7 封推荐信(78%)被认为是有帮助的,8/22(36%)种抗胆碱能药物被停用,减少了 7 名患者的抗胆碱能负荷。与未更换药物的患者相比,抗胆碱能药物负荷减少的患者的记忆评估结果在两周后有了明显改善(6 ± 3 分 vs. -1 ± 6 分):结论:该方法深受参与医生的欢迎,可支持标准化的抗胆碱能药物处方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drugs & Aging
Drugs & Aging 医学-老年医学
CiteScore
5.50
自引率
7.10%
发文量
68
审稿时长
6-12 weeks
期刊介绍: Drugs & Aging delivers essential information on the most important aspects of drug therapy to professionals involved in the care of the elderly. The journal addresses in a timely way the major issues relating to drug therapy in older adults including: the management of specific diseases, particularly those associated with aging, age-related physiological changes impacting drug therapy, drug utilization and prescribing in the elderly, polypharmacy and drug interactions.
期刊最新文献
Opioid Prescriptions for Low Back Pain among Military-Connected Older Adults Across Multiple Care Systems. Correction: Anticholinergic Exposure, Drug Dose and Postoperative Delirium: Comparison of Dose-Related and Non-Dose-Related Anticholinergic Burden Scores in a Retrospective Cohort Study of Older Orthopaedic and Trauma Surgery Patients. Patient-Centric Approach for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease in Older People. Osteoporosis in Older Men: Informing Patient Management and Improving Health-Related Outcomes. Exploring Hyperkalemia Risk in Frail Older Patients Using RAAS Inhibitors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1